Biomarkers that are predictive of clinical benefit in Trop-2-expressing triple-negative breast cancer – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Nov 3 2020
Oncotarget recently published “Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer” which reporte… [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *